Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FH0AY
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,906
Award facts
- Contract value 100% obligated
- $13,906.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $13,906.31 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 mL pen injectors on August 18, 2025, with an ultimate completion date of August 19, 2025. The contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. Dupixent is a prescription medication used to treat conditions including atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, making this procurement consistent with DLA's broader mission to supply pharmaceutical products for military and federal healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical vendor for federal medical procurement through its comprehensive product portfolio spanning specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. As the prime contractor on this delivery order, AmerisourceBergen leverages its DLA Troop Support Medical contract to fulfill pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's consistent receipt of competitively awarded, non-set-aside contracts demonstrates its capability to meet rigorous federal procurement standards and deliver medical commodities efficiently to support military healthcare operations.
Quick answers
Who was awarded contract SPE2DB25FH0AY?
SPE2DB25FH0AY was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 18, 2025.
How much is contract SPE2DB25FH0AY worth?
The government has obligated $13,906 on SPE2DB25FH0AY.
Is contract SPE2DB25FH0AY an order under another contract?
Yes. SPE2DB25FH0AY is a delivery order under SPE2DB22D1017, an indefinite delivery contract.
Was contract SPE2DB25FH0AY competed?
The extent of competition for SPE2DB25FH0AY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award